Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
41 hedge funds and large institutions have $31.7M invested in Alimera Sciences in 2019 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
5% more funds holding
Funds holding: 39 → 41 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less capital invested
Capital invested by funds: $38.2M → $31.7M (-$6.49M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
+$1.05M |
| 2 |
Renaissance Technologies
New York
|
+$122K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$51.3K |
| 4 |
DMK
David M. Knott
|
+$39K |
| 5 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
+$19.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$1.03M |
| 2 |
BRF
B. Riley Financial
Los Angeles,
California
|
-$303K |
| 3 |
BlackRock
New York
|
-$135K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$97K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$41.4K |
ALIM Hedge Fund Activity: Q2 2019 in Review
41 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2019, worth a combined $31.7M — down 17% from $38.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ALIM positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 9 trimmed.
The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $1.05M. The largest seller was Armistice Capital, cutting an estimated $1.03M.
- 41 institutional investors held Alimera Sciences (ALIM) as of Q2 2019, up from 39 in Q1 2019.
- Funds reported $31.7M of Alimera Sciences stock for Q2 2019, down 17% quarter-over-quarter.
- 7 funds opened new Alimera Sciences positions in Q2 2019 and 5 closed out, a net change of +2 holders.
- The largest Alimera Sciences buyer in Q2 2019 was Boothbay Fund Management, an estimated $1.05M added.
- The largest Alimera Sciences seller in Q2 2019 was Armistice Capital, an estimated $1.03M sold.
Based on aggregated 13F filings for Q2 2019.